IL17A and chronic obstructive pulmonary disease: In chronic obstructive pulmonary disease (COPD), IL-35 levels correlate with disease characteristics alongside IL-17 and IL-10, positioning IL-35 as a potential biomarker for disease monitoring and therapeutic targeting [46].